tiprankstipranks
Trending News
More News >
Guided Therapeutics Inc (GTHP)
OTHER OTC:GTHP
US Market
Advertisement

Guided Therapeutics (GTHP) Technical Analysis

Compare
27 Followers

Technical Sentiment

Overall Consensus
Strong Buy
14Bullish
5Neutral
2Bearish
Technical Analysis Consensus
Neutral
2Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Guided Therapeutics Inc’s (GTHP) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting Guided Therapeutics Inc is a Buy.
Guided Therapeutics Inc’s (GTHP) 20-Day exponential moving average is 0.27, while Guided Therapeutics Inc’s (GTHP) share price is $0.28, making it a Buy.
Guided Therapeutics Inc’s (GTHP) 50-Day exponential moving average is 0.25, while Guided Therapeutics Inc’s (GTHP) share price is $0.28, making it a Buy.

Guided Therapeutics (GTHP) Pivot Points

Sep 22, 2025, 12:37 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.26
0.26
0.26
0.26
0.26
0.26
0.26
Fibonacci
0.26
0.26
0.26
0.26
0.26
0.26
0.26
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Guided Therapeutics (GTHP) Moving Averages

Sep 22, 2025, 12:37 PM
Period
Simple
Exponential
MA5
0.27Buy
0.27Buy
MA10
0.28Buy
0.27Buy
MA20
0.27Buy
0.27Buy
MA50
0.25Buy
0.25Buy
MA100
0.21Buy
0.22Buy
MA200
0.17Buy
0.19Buy
Guided Therapeutics Inc’s (GTHP) 10-Day exponential moving average is 0.27, while Guided Therapeutics Inc’s (GTHP) share price is $0.28, making it a Buy.
Guided Therapeutics Inc’s (GTHP) 100-Day exponential moving average is 0.22, while Guided Therapeutics Inc’s (GTHP) share price is $0.28, making it a Buy.
Guided Therapeutics Inc’s (GTHP) stock price is $0.28 and Guided Therapeutics Inc’s (GTHP) 50-day simple moving average is 0.25, creating a Buy signal.
Guided Therapeutics Inc’s (GTHP) stock price is $0.28 and Guided Therapeutics Inc’s (GTHP) 100-day simple moving average is 0.21, creating a Buy signal.
Guided Therapeutics Inc’s (GTHP) stock price is $0.28 and Guided Therapeutics Inc’s (GTHP) 200-day simple moving average is 0.17, creating a Buy signal.

Guided Therapeutics (GTHP) Technical Indicators

Sep 22, 2025, 12:37 PM
Name
Value
Implied Action
RSI (14)
53.81
Neutral
STOCH (9,6)
66.67
Neutral
STOCHRSI (14)
66.67
Neutral
MACD (12,26)
<0.01
Buy
ADX (14)
24.85
Neutral
Williams %R
-20.00
Sell
CCI (14)
-17.57
Neutral
ATR (14)
0.03
-
Ultimate Oscillator
73.18
Buy
ROC
0.00
Sell
Guided Therapeutics Inc’s (GTHP) Relative Strength Index (RSI) is 53.81, creating a Neutral signal.
Guided Therapeutics Inc’s (GTHP) Trend Strength Indicator (ADX) is 24.85, creating a Neutral signal.
Guided Therapeutics Inc’s (GTHP) Commodity Channel Index (CCI) is -17.57, creating a Neutral signal.

FAQ

Is GTHP a Buy, Hold, or Sell?
Based on GTHP’s technical indicators, GTHP is a Strong Buy.
    What is GTHP’s RSI (14)?
    GTHP’s RSI (14) is 53.81, which suggests GTHP is a Neutral.
      What is GTHP’s MACD?
      GTHP’s MACD is <0.01, which suggests GTHP is a Buy.
        What is GTHP’s 5-day moving average?
        GTHP’s 5-day moving average is 0.27, which suggests GTHP is a Buy.
          What is GTHP’s 20-day moving average?
          GTHP 20-day moving average is 0.27, which suggests GTHP is a Buy.
            What is GTHP’s 50-day moving average?
            GTHP’s 50-day moving average is 0.25, which suggests GTHP is a Buy.
              What is GTHP’s 200-day moving average?
              GTHP’s 200-day moving average is 0.17, which suggests GTHP is a Buy.
                What is GTHP’s Williams % R (14)?
                GTHP’s Williams % R (14) is -20.00, which suggests GTHP is a Sell.
                  What is GTHP’s CCI (14)?
                  GTHP’s CCI (14) is -17.57, which suggests GTHP is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis